AAA’s Support Goes the Extra Mile
BRI’s work took on new meaning for Kirk Nelson when his wife, Patty, was diagnosed with a rare disease called autoimmune dermatomyositis.
“I’d heard of BRI,” says Kirk, CEO of AAA Washington. “And the more we researched my wife’s condition, the more comforting it became that a local organization was working toward cures for diseases like hers.”
Kirk is proving that individual supporters can make a big difference at BRI: He recently joined our board of directors, and he spurred AAA to make a generous donation at this year’s Illuminations Luncheon.
“One of our guiding principles is to care for our community,” Kirk says. “Supporting BRI aligns with that because autoimmune diseases impact many colleagues and their families.”
He’s also furthering AAA’s support by encouraging their Washington-based employees to become research participants for the Sound Life Project.
“Autoimmune diseases are so common and so debilitating, which means BRI’s work has the potential to have a huge impact,” Kirk says. “We’ll do anything we can to help.”
You Might Also Like
Two Half-Marathons in Two Days on Two Coasts to Support BRI
Learn about the challenge Gretchen Schoenstein took on to raise funds and awareness for BRI.
Passing on the Hope: What I Learned Running Two Half-Marathons on Two Coasts in Two Days
Gretchen reflects on her journey from Washington, D.C., to Portland, Oregon, as she ran back-to-back half-marathons to raise autoimmune disease awareness and support immune system disease research at BRI.
2 Halfs, 2 Coasts, 2 Days: Gretchen Schoenstein Takes on Challenge for BRI and Everyone with Autoimmune Diseases
Longtime BRI supporter Gretchen Schoenstein is taking on a bold new challenge: 2 half-marathons, in 2 days, on 2 coasts. And she’ll raise $20,000 for autoimmune disease research at Benaroya Research Institute (BRI).
Gretchen shares what inspired her to take on this challenge, why she supports BRI, and her experience running more than 120 half-marathons while living with multiple autoimmune diseases.
Immuno-what? Hear the latest from BRI
Keep up to date on our latest research, new clinical trials and exciting publications.